Skip to main content

LIVE

IMCC

IM Cannabis Corp.

IMCC

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $1.2M

$1.98

-10.00%

P/E

Mkt Cap

$1.2M

52-Wk Range

$1.95–$77.10

52-Week Range

$1.95 - $77.10

P/E

Fwd P/E

Beta

2.10

Div Yield

0.00%

Avg Vol

152.3K

Shares Out

3.1M

Mkt Cap

$1.2M

Price action

Price chart

Down 96.4% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Multi-jurisdictional licensing and operations across three major cannabis markets
  • Vertically integrated cultivation and production capabilities
  • Established brand portfolio with consumer recognition in medical and recreational segments
  • Strategic geographic diversification reducing regulatory and market concentration risk

Bear Case

1 risk

  • High volatility (beta 2.1). Larger-than-normal price swings expected.

Growth

Moderate growth ahead

Expanding medical cannabis adoption and prescription rates globally

Value

Valuation data unavailable

Momentum

Falling

-77.7% over 3m

Quality

Stable

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 16, 2026

Q3 26 RECAP

AUG 13, 2026

Most recent quarter reported revenue of $4.6M. Reported EPS of -$0.28.

Reported EPS · last 4Q

0 of 1 beats

Q3 26

Revenue trend · last 8Q

+4%

-14%

-0%

+18%

-50%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$10.8M

$10.2M

$9.8M

$9.2M

$9.3M

$10.2M

$11.5M

$4.6M

Margins · last 8Q

Gross

Operating

Profit

-26.2%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

vs Industry

How IMCC stacks vs Drug Manufacturers - Specialty & Generic

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.